HEALTHPEAK PROPERTIES INC (DOC) Fundamental Analysis & Valuation
NYSE:DOC • US42250P1030
Current stock price
16.52 USD
+0.14 (+0.85%)
At close:
16.6805 USD
+0.16 (+0.97%)
After Hours:
This DOC fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. DOC Profitability Analysis
1.1 Basic Checks
- DOC had positive earnings in the past year.
- DOC had a positive operating cash flow in the past year.
- DOC had positive earnings in each of the past 5 years.
- DOC had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
- With a Return On Assets value of 0.35%, DOC perfoms like the industry average, outperforming 47.54% of the companies in the same industry.
- DOC has a Return On Equity (0.94%) which is comparable to the rest of the industry.
- DOC has a Return On Invested Capital of 2.24%. This is comparable to the rest of the industry: DOC outperforms 40.98% of its industry peers.
- Measured over the past 3 years, the Average Return On Invested Capital for DOC is in line with the industry average of 3.11%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.35% | ||
| ROE | 0.94% | ||
| ROIC | 2.24% |
ROA(3y)1.17%
ROA(5y)1.99%
ROE(3y)2.87%
ROE(5y)4.76%
ROIC(3y)2.27%
ROIC(5y)2.16%
1.3 Margins
- The Profit Margin of DOC (2.50%) is comparable to the rest of the industry.
- In the last couple of years the Profit Margin of DOC has declined.
- The Operating Margin of DOC (19.31%) is comparable to the rest of the industry.
- In the last couple of years the Operating Margin of DOC has grown nicely.
- The Gross Margin of DOC (60.00%) is worse than 68.03% of its industry peers.
- DOC's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 19.31% | ||
| PM (TTM) | 2.5% | ||
| GM | 60% |
OM growth 3Y0.32%
OM growth 5Y7.81%
PM growth 3Y-53.06%
PM growth 5Y-36.91%
GM growth 3Y1.1%
GM growth 5Y2.84%
2. DOC Health Analysis
2.1 Basic Checks
- DOC has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
- The number of shares outstanding for DOC has been reduced compared to 1 year ago.
- DOC has more shares outstanding than it did 5 years ago.
- DOC has a worse debt/assets ratio than last year.
2.2 Solvency
- Based on the Altman-Z score of 0.31, we must say that DOC is in the distress zone and has some risk of bankruptcy.
- DOC's Altman-Z score of 0.31 is in line compared to the rest of the industry. DOC outperforms 44.26% of its industry peers.
- DOC has a Debt/Equity ratio of 1.27. This is a high value indicating a heavy dependency on external financing.
- With a Debt to Equity ratio value of 1.27, DOC perfoms like the industry average, outperforming 49.18% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.27 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 0.31 |
ROIC/WACC0.38
WACC5.95%
2.3 Liquidity
- A Current Ratio of 0.48 indicates that DOC may have some problems paying its short term obligations.
- DOC's Current ratio of 0.48 is on the low side compared to the rest of the industry. DOC is outperformed by 74.59% of its industry peers.
- A Quick Ratio of 0.48 indicates that DOC may have some problems paying its short term obligations.
- With a Quick ratio value of 0.48, DOC is not doing good in the industry: 74.59% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.48 | ||
| Quick Ratio | 0.48 |
3. DOC Growth Analysis
3.1 Past
- The earnings per share for DOC have decreased by 0.00% in the last year.
- DOC shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -16.06% yearly.
- Looking at the last year, DOC shows a small growth in Revenue. The Revenue has grown by 4.52% in the last year.
- Measured over the past years, DOC shows a quite strong growth in Revenue. The Revenue has been growing by 11.40% on average per year.
EPS 1Y (TTM)0%
EPS 3Y-27.44%
EPS 5Y-16.06%
EPS Q2Q%1500%
Revenue 1Y (TTM)4.52%
Revenue growth 3Y11.05%
Revenue growth 5Y11.4%
Sales Q2Q%3.07%
3.2 Future
- DOC is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 0.77% yearly.
- The Revenue is expected to grow by 5.62% on average over the next years.
EPS Next Y-37.96%
EPS Next 2Y-16.2%
EPS Next 3Y-9.72%
EPS Next 5Y0.77%
Revenue Next Year1.94%
Revenue Next 2Y3.03%
Revenue Next 3Y4.42%
Revenue Next 5Y5.62%
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. DOC Valuation Analysis
4.1 Price/Earnings Ratio
- With a Price/Earnings ratio of 47.20, DOC can be considered very expensive at the moment.
- Compared to the rest of the industry, the Price/Earnings ratio of DOC is on the same level as its industry peers.
- DOC is valuated expensively when we compare the Price/Earnings ratio to 25.60, which is the current average of the S&P500 Index.
- The Price/Forward Earnings ratio is 76.08, which means the current valuation is very expensive for DOC.
- The rest of the industry has a similar Price/Forward Earnings ratio as DOC.
- When comparing the Price/Forward Earnings ratio of DOC to the average of the S&P500 Index (22.84), we can say DOC is valued expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 47.2 | ||
| Fwd PE | 76.08 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, DOC is valued a bit cheaper than the industry average as 61.48% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 12.95 |
4.3 Compensation for Growth
- A cheap valuation may be justified as DOC's earnings are expected to decrease with -9.72% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-16.2%
EPS Next 3Y-9.72%
5. DOC Dividend Analysis
5.1 Amount
- With a Yearly Dividend Yield of 7.27%, DOC is a good candidate for dividend investing.
- DOC's Dividend Yield is a higher than the industry average which is at 7.54.
- DOC's Dividend Yield is rather good when compared to the S&P500 average which is at 1.88.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 7.27% |
5.2 History
- The dividend of DOC decreases each year by -4.20%.
- DOC has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)-4.2%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
- 1204.15% of the earnings are spent on dividend by DOC. This is not a sustainable payout ratio.
DP1204.15%
EPS Next 2Y-16.2%
EPS Next 3Y-9.72%
DOC Fundamentals: All Metrics, Ratios and Statistics
16.52
+0.14 (+0.85%)
Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)02-02 2026-02-02/amc
Earnings (Next)04-22 2026-04-22
Inst Owners97.68%
Inst Owner Change-96.4%
Ins Owners0.23%
Ins Owner Change1.26%
Market Cap11.49B
Revenue(TTM)2.82B
Net Income(TTM)70.51M
Analysts73.91
Price Target19.83 (20.04%)
Short Float %4.29%
Short Ratio3.25
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 7.27% |
Yearly Dividend1.22
Dividend Growth(5Y)-4.2%
DP1204.15%
Div Incr Years0
Div Non Decr Years0
Ex-Date03-17 2026-03-17 (0.10167)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)108.65%
Min EPS beat(2)37.75%
Max EPS beat(2)179.54%
EPS beat(4)3
Avg EPS beat(4)52.57%
Min EPS beat(4)-19.41%
Max EPS beat(4)179.54%
EPS beat(8)5
Avg EPS beat(8)31.44%
EPS beat(12)8
Avg EPS beat(12)38.23%
EPS beat(16)11
Avg EPS beat(16)56.93%
Revenue beat(2)2
Avg Revenue beat(2)1.99%
Min Revenue beat(2)0.94%
Max Revenue beat(2)3.04%
Revenue beat(4)3
Avg Revenue beat(4)1.41%
Min Revenue beat(4)-0.37%
Max Revenue beat(4)3.04%
Revenue beat(8)7
Avg Revenue beat(8)2.35%
Revenue beat(12)9
Avg Revenue beat(12)-4.49%
Revenue beat(16)11
Avg Revenue beat(16)-3.26%
PT rev (1m)0%
PT rev (3m)-4.22%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-3.23%
EPS NY rev (1m)-17.76%
EPS NY rev (3m)-18.7%
Revenue NQ rev (1m)-0.33%
Revenue NQ rev (3m)-1.22%
Revenue NY rev (1m)0.28%
Revenue NY rev (3m)-0.6%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 47.2 | ||
| Fwd PE | 76.08 | ||
| P/S | 4.07 | ||
| P/FCF | N/A | ||
| P/OCF | 9.17 | ||
| P/B | 1.53 | ||
| P/tB | 1.69 | ||
| EV/EBITDA | 12.95 |
EPS(TTM)0.35
EY2.12%
EPS(NY)0.22
Fwd EY1.31%
FCF(TTM)-0.19
FCFYN/A
OCF(TTM)1.8
OCFY10.9%
SpS4.06
BVpS10.79
TBVpS9.75
PEG (NY)N/A
PEG (5Y)N/A
Graham Number9.22
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.35% | ||
| ROE | 0.94% | ||
| ROCE | 2.84% | ||
| ROIC | 2.24% | ||
| ROICexc | 2.3% | ||
| ROICexgc | 2.51% | ||
| OM | 19.31% | ||
| PM (TTM) | 2.5% | ||
| GM | 60% | ||
| FCFM | N/A |
ROA(3y)1.17%
ROA(5y)1.99%
ROE(3y)2.87%
ROE(5y)4.76%
ROIC(3y)2.27%
ROIC(5y)2.16%
ROICexc(3y)2.3%
ROICexc(5y)2.18%
ROICexgc(3y)2.51%
ROICexgc(5y)2.37%
ROCE(3y)2.87%
ROCE(5y)2.73%
ROICexgc growth 3Y5.01%
ROICexgc growth 5Y15.76%
ROICexc growth 3Y4.44%
ROICexc growth 5Y15.37%
OM growth 3Y0.32%
OM growth 5Y7.81%
PM growth 3Y-53.06%
PM growth 5Y-36.91%
GM growth 3Y1.1%
GM growth 5Y2.84%
F-Score6
Asset Turnover0.14
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.27 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 5.92 | ||
| Cap/Depr | 130.74% | ||
| Cap/Sales | 49.05% | ||
| Interest Coverage | 2.1 | ||
| Cash Conversion | 78.06% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.48 | ||
| Quick Ratio | 0.48 | ||
| Altman-Z | 0.31 |
F-Score6
WACC5.95%
ROIC/WACC0.38
Cap/Depr(3y)104.54%
Cap/Depr(5y)153.18%
Cap/Sales(3y)38.39%
Cap/Sales(5y)55.21%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0%
EPS 3Y-27.44%
EPS 5Y-16.06%
EPS Q2Q%1500%
EPS Next Y-37.96%
EPS Next 2Y-16.2%
EPS Next 3Y-9.72%
EPS Next 5Y0.77%
Revenue 1Y (TTM)4.52%
Revenue growth 3Y11.05%
Revenue growth 5Y11.4%
Sales Q2Q%3.07%
Revenue Next Year1.94%
Revenue Next 2Y3.03%
Revenue Next 3Y4.42%
Revenue Next 5Y5.62%
EBIT growth 1Y-3.69%
EBIT growth 3Y11.4%
EBIT growth 5Y20.1%
EBIT Next Year254.56%
EBIT Next 3Y58.98%
EBIT Next 5Y35.87%
FCF growth 1Y-137.77%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y16.95%
OCF growth 3Y11.62%
OCF growth 5Y10.54%
HEALTHPEAK PROPERTIES INC / DOC Fundamental Analysis FAQ
Can you provide the ChartMill fundamental rating for HEALTHPEAK PROPERTIES INC?
ChartMill assigns a fundamental rating of 3 / 10 to DOC.
What is the valuation status for DOC stock?
ChartMill assigns a valuation rating of 1 / 10 to HEALTHPEAK PROPERTIES INC (DOC). This can be considered as Overvalued.
How profitable is HEALTHPEAK PROPERTIES INC (DOC) stock?
HEALTHPEAK PROPERTIES INC (DOC) has a profitability rating of 5 / 10.
Can you provide the financial health for DOC stock?
The financial health rating of HEALTHPEAK PROPERTIES INC (DOC) is 1 / 10.
Is the dividend of HEALTHPEAK PROPERTIES INC sustainable?
The dividend rating of HEALTHPEAK PROPERTIES INC (DOC) is 5 / 10 and the dividend payout ratio is 1204.15%.